Dr. Ferreira is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
508 S Habana Ave
Ste 340
Tampa, FL 33609Phone+1 813-873-7367Fax+1 813-875-9722
Education & Training
- Zucker School of Medicine at Hofstra/Northwell at Cohen Children's Medical CenterFellowship, Child Neurology, 1990 - 1993
- Yale-New Haven Medical CenterResidency, Pediatrics, 1988 - 1990
- Universidad Central del Este Facultad de MedicinaClass of 1986
Certifications & Licensure
- FL State Medical License 1994 - 2025
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- American Board of Psychiatry and Neurology Epilepsy
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Phase II Trial With Subcutaneous Immunotherapy in Patients Sensitized to Phleum Pratense Start of enrollment: 2011 Oct 01
- A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder Start of enrollment: 2023 Aug 16
Roles: Contact
Publications & Presentations
PubMed
- 19 citationsSafety and tolerability of adjunctive lacosamide in a pediatric population with focal seizures - An open-label trialJose A. Ferreira, Jean-Baptiste Le Pichon, Ahmed Abdelmoity, Deanne Dilley, Peter Dedeken
Seizure. 2019-10-01 - 25 citationsExploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications.Manuel Neves, Rita Azevedo, Luís Lima, Marta I. Oliveira, Andreia F. Peixoto
New Biotechnology. 2019-03-25 - 25 citationsAdjunctive Perampanel Oral Suspension in Pediatric Patients From ≥2 to <12 Years of Age With Epilepsy: Pharmacokinetics, Safety, Tolerability, and Efficacy:J. Ben Renfroe, Mark Mintz, Ronald W. Davis, Jose A. Ferreira, Sharon Dispoto
Journal of Child Neurology. 2019-02-10
Press Mentions
- LivaNova Launches Global Clinical Registry to Assess VNS Therapy Treatment for Drug-Resistant Epilepsy PatientsAugust 24th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: